KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Long-Term Investments (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Long-Term Investments for 9 consecutive years, with $995000.0 as the latest value for Q1 2025.

  • Quarterly Long-Term Investments fell 80.37% to $995000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $995000.0 through Mar 2025, down 80.37% year-over-year, with the annual reading at $995000.0 for FY2024, 80.37% down from the prior year.
  • Long-Term Investments for Q1 2025 was $995000.0 at Biolife Solutions, roughly flat from $995000.0 in the prior quarter.
  • The five-year high for Long-Term Investments was $5.1 million in Q4 2022, with the low at $995000.0 in Q2 2024.
  • Average Long-Term Investments over 4 years is $3.3 million, with a median of $5.1 million recorded in 2022.
  • The sharpest move saw Long-Term Investments changed 0.0% in 2023, then crashed 80.37% in 2024.
  • Over 4 years, Long-Term Investments stood at $5.1 million in 2022, then changed by 0.0% to $5.1 million in 2023, then plummeted by 80.37% to $995000.0 in 2024, then changed by 0.0% to $995000.0 in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $995000.0, $995000.0, and $995000.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.